Case Evaluation
Over $150 Million Collected for Plantiffs in 2011


Date posted: 9/27/2012

September 24, 2012 – With experts linking the blood thinner Pradaxa to severe internal bleeding and hundreds filing lawsuits for injury or death, a federal judge recently scheduled an initial hearing and indicated when trials would begin.

If you have been affected by internal bleeding or the loss of a loved one from Pradaxa, it is important to speak with a lawyer about your legal options as soon as possible. You may be entitled to substantial compensation.

Pradaxa is a popular anticoagulant drug prescribed to stop strokes and blood clots in patients with atrial fibrillation. Although only on the market since October, 2010, the drug has earned over $1 billion for manufacturer Boehringer Ingelheim and has been used in over 70 countries.

On December 7, 2011, however, the FDA announced that it was investigating the safety of Pradaxa after receiving more injury or death reports than expected. In 2011, the agency received 3,781 reports of side effects and 542 deaths among Pradaxa users, more than all other medications.

Due to the number of claims expected, a central court was recently established in Illinois to handle the lawsuits. So far, more than 100 people have filed a case. Although Boehringer Ingelheim tried to have these cases dismissed, a federal judge has denied their attempts.

Judge Herndon has also set an initial hearing for October 3rd and indicated trials should start in 18 to 24 months.

Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of these federal MDL cases, the Pradaxa Resource center only recommends lawyers who are already handling Pradaxa lawsuits.

Contact us today to speak with a lawyer, or for more information on the research, warnings, side effects and legal options relating to the drug Pradaxa.


Facebook Twitter Youtube